Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter J Little

Showing results (181-190 of 185) with videos related to

Pageof 19
Sort By:
You have reached the last page of results.This site can display upto 185 results.
Acta Pharmacologica Sinica|August 29, 2023
Animal models of heart failure with preserved ejection fraction (HFpEF): from metabolic pathobiology to drug discoverySi Gao, Xue-Ping Liu, Ting-Ting Li, et al.
Science Bulletin|April 17, 2026
Hepatic IFRD1 suppresses metabolic dysfunction-associated fatty liver disease via GLUD1/α-KG axisMengya Geng, Fanzheng Meng, Hairui Li, et al.
Pharmacological Reviews|June 5, 2021
Endothelial Dysfunction in Atherosclerotic Cardiovascular Diseases and Beyond: From Mechanism to PharmacotherapiesSuowen Xu, Iqra Ilyas, Peter J Little, et al.
Journal of Advanced Research|March 3, 2024
Moscatilin inhibits vascular calcification by activating IL13RA2-dependent inhibition of STAT3 and attenuating the WNT3/β-catenin signalling pathwayTingting Zhang, Mengmeng Zhu, Jialing Ma, et al.
Science Advances|March 26, 2025
The clinical antiprotozoal drug halofuginone promotes weight loss by elevating GDF15 and FGF21Suowen Xu, Zhenghong Liu, Tian Tian, et al.
Pageof 19

Showing results (181-190 of 185) with videos related to

Sort By:
Pageof 19
You have reached the last page of results.This site can display upto 185 results.
Acta Pharmacologica Sinica|August 29, 2023
Animal models of heart failure with preserved ejection fraction (HFpEF): from metabolic pathobiology to drug discoverySi Gao, Xue-Ping Liu, Ting-Ting Li, et al.
Science Bulletin|April 17, 2026
Hepatic IFRD1 suppresses metabolic dysfunction-associated fatty liver disease via GLUD1/α-KG axisMengya Geng, Fanzheng Meng, Hairui Li, et al.
Pharmacological Reviews|June 5, 2021
Endothelial Dysfunction in Atherosclerotic Cardiovascular Diseases and Beyond: From Mechanism to PharmacotherapiesSuowen Xu, Iqra Ilyas, Peter J Little, et al.
Journal of Advanced Research|March 3, 2024
Moscatilin inhibits vascular calcification by activating IL13RA2-dependent inhibition of STAT3 and attenuating the WNT3/β-catenin signalling pathwayTingting Zhang, Mengmeng Zhu, Jialing Ma, et al.
Science Advances|March 26, 2025
The clinical antiprotozoal drug halofuginone promotes weight loss by elevating GDF15 and FGF21Suowen Xu, Zhenghong Liu, Tian Tian, et al.
Pageof 19